Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1131691021
rs1131691021
0.010 GeneticVariation BEFREE Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma. 30353028

2018

dbSNP: rs121913529
rs121913529
0.010 GeneticVariation BEFREE Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma. 30353028

2018

dbSNP: rs1444669684
rs1444669684
0.010 GeneticVariation BEFREE Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma. 30353028

2018

dbSNP: rs762846821
rs762846821
0.010 GeneticVariation BEFREE Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma. 30353028

2018

dbSNP: rs1413563094
rs1413563094
0.010 GeneticVariation BEFREE A partial response occurred in 2 (8%) of the evaluable patients (95% CI, 1.0-26.0), one with <i>PIK3CA</i> E542K-mutant embryonal rhabdomyosarcoma and another with spindle cell sarcoma. 28377484

2017

dbSNP: rs113488022
rs113488022
0.010 GeneticVariation BEFREE Tumour engraftment permits dynamic imaging of neovascularization, niche partitioning of tumour-propagating cells in embryonal rhabdomyosarcoma, emergence of clonal dominance in T-cell acute lymphoblastic leukaemia and tumour evolution resulting in elevated growth and metastasis in BRAF(V600E)-driven melanoma. 26790525

2016

dbSNP: rs121913377
rs121913377
0.010 GeneticVariation BEFREE Tumour engraftment permits dynamic imaging of neovascularization, niche partitioning of tumour-propagating cells in embryonal rhabdomyosarcoma, emergence of clonal dominance in T-cell acute lymphoblastic leukaemia and tumour evolution resulting in elevated growth and metastasis in BRAF(V600E)-driven melanoma. 26790525

2016

dbSNP: rs762471803
rs762471803
0.010 GeneticVariation BEFREE Consistent with its oncogene function, TAZ S89A induced expression of the ERMS cancer stem cell gene Myf5 and the serine biosynthesis pathway (Phgdh, Psat1, Psph) in C2C12 myoblasts. 27184927

2016